Time-Varying Cardiovascular Effects of Sodium-Glucose Cotransporter Inhibitors in Patients With Hear...
Time-Varying Cardiovascular Effects of Sodium-Glucose Cotransporter Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Both the EMPEROR-Preserved (he Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction) and DELIVER (Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure) trials showed that sodium-glucose cotransporter inhibitors (SGLTis) reduced the risk of composite e...
Alternative Titles
Full title
Time-Varying Cardiovascular Effects of Sodium-Glucose Cotransporter Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2835280343
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2835280343
Other Identifiers
ISSN
0002-9149
E-ISSN
1879-1913
DOI
10.1016/j.amjcard.2023.06.057
